SCHEMBL3722341

SCHEMBL3722341

COC(=O)C(C(=O)OC(C)(C)C)c1ccc([N+](=O)[O-])c(C(=O)N(C)C)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.41
KMT2A Q03164 4/20 0.38
NPSR1 Q6W5P4 2/20 0.38
MEN1 O00255 1/20 0.38
HPGD P15428 1/20 0.38
L3MBTL1 Q9Y468 3/20 0.36
GSTP1 P09211 1/20 0.36
GSTM2 P28161 1/20 0.36
HTT P42858 1/20 0.36
PKM P14618 1/20 0.35
CHEK1 O14757 1/20 0.35
HKDC1 Q2TB90 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
MAPT P10636 2/20 0.33
MAPK1 P28482 2/20 0.33
SIRT6 Q8N6T7 1/20 0.33
LMNA P02545 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
ADRB2 P07550 1/20 0.33
FAAH O00519 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12185923 0.92 ALDH1A1 (0.48) ALDH1A1KMT2ANPSR1MEN1HPGD
SCHEMBL2597715 0.82 KMT2A (0.41) ALDH1A1KMT2ANPSR1MEN1HPGD
SCHEMBL3723602 0.81 ALDH1A1 (0.45) ALDH1A1KMT2ANPSR1MEN1L3MBTL1
SCHEMBL2597772 0.78 KMT2A (0.46) ALDH1A1KMT2ANPSR1MEN1HPGD
SCHEMBL2597771 0.78 KMT2A (0.46) ALDH1A1KMT2ANPSR1MEN1HPGD
SCHEMBL2437569 0.76 TDP1 (0.44) ALDH1A1KMT2ANPSR1L3MBTL1GSTP1
SCHEMBL2761732 0.76 SLC6A3 (0.48) ALDH1A1KMT2AMEN1HPGDMAPT
SCHEMBL3651078 0.74 SIRT6 (0.45) ALDH1A1KMT2ANPSR1MEN1HPGD
SCHEMBL20703719 0.73 MAPT (0.41) ALDH1A1KMT2AMEN1L3MBTL1GSTP1
SCHEMBL16413095 0.73 ALDH1A1 (0.66) ALDH1A1KMT2AMEN1PKMSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100158996-A1 ESTER COMPOUND AND MEDICAL USE THEREOF JAPAN TOBACCO INC. 2010-06-24 US disclosed
US-7625948-B2 Ester compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2009-12-01 US disclosed
US-20050075367-A1 Ester compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2005-04-07 US disclosed
EP-1479666-A1 ESTER COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2004-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050075367-A1 Ester compound and medicinal use thereof LIPC, CES1, MTTP ALDH1A1 564/4885KMT2A 2890/4885NPSR1 2618/4885
US-20100158996-A1 ESTER COMPOUND AND MEDICAL USE THEREOF LIPC, CES1, MTTP ALDH1A1 603/4885KMT2A 3106/4885NPSR1 2364/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.